Morphologic Damage of Rat Alveolar Epithelial Type II Cells Induced by Bile Acids Could Be Ameliorated by Farnesoid X Receptor Inhibitor Z-Guggulsterone In Vitro

Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels

(2015) Laura Brouwers et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy

(2014) Elena Lopez-Rodriguez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Effects of Bile Acids and the Bile Acid Receptor FXR Agonist on the Respiratory Rhythm in the In Vitro Brainstem Medulla Slice of Neonatal Sprague-Dawley Rats

(2014) Cong Zhao et al.   PLoS One

Effect of Bile Acid on Fetal Lung in Rat Model of Intrahepatic Cholestasis of Pregnancy

(2014) Ling Yu et al.   International Journal of Endocrinology

European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update

(2013) David G. Sweet et al.   Neonatology

Bile acids increase alveolar epithelial permeability via mitogen-activated protein kinase, cytosolic phospholipase A2, cyclooxygenase-2, prostaglandin E2and junctional proteins

(2013) Kang-Cheng Su et al.   RESPIROLOGY

Glycochenodeoxycholate induces rat alveolar epithelial type II cell death and inhibits surfactant secretion in vitro

(2012) Hu Zhangxue et al.   FREE RADICAL BIOLOGY AND MEDICINE

Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates

(2011) Daniele De Luca et al.   INTENSIVE CARE MEDICINE

Bile acids as regulatory molecules

(2009) Phillip B. Hylemon et al.   JOURNAL OF LIPID RESEARCH

Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration

(2008) Daniele De Luca et al.   INTENSIVE CARE MEDICINE

Bile Acid-Induced Lung Injury in Newborn Infants: A Bronchoalveolar Lavage Fluid Study

(2008) E. Zecca et al.   PEDIATRICS